Precigen, Inc. (NASDAQ:PGEN) Q4 2024 Earnings Conference Call March 19, 2025 4:30 PM ET
Company Participants
Steven Harasym – IR
Helen Sabzevari – President and CEO
Rutul Shah – COO
Phil Tennant – CCO
Harry Thomasian – CFO
Conference Call Participants
Jason Butler – Citizens
Carolina Ibanez Ventoso – Stifel
Swayampakula Ramakanth – H.C. Wainwright
Jennifer Kim – Cantor
Brian Cheng – JPMorgan
Operator
Good evening, and welcome to the Precigen’s Full Year 2024 Financial Results and Business Update Call. At this time, all lines are in listen-only mode. Following the prepared remarks, there will be a question-and-answer session. Please note that this event is being recorded. I would now like to turn the conference over to Steve Harasym from Investor Relations. Please go ahead.
Steven Harasym
Thank you, Alan, and thank you for everyone joining us this afternoon. With me today are Dr. Helen Sabzevari, President and CEO of Precigen; Harry Thomasian, our CFO; Phil Tennant, our Chief Commercial Officer; and Rutul Shah, our Chief Operating Officer.
Before we begin, let me briefly review our forward-looking statements. During today’s call, we will make various forward-looking statements. Investors are cautioned that our forward-looking statements are based on current expectations and are subject to risks and uncertainties that could cause actual results or outcomes to differ from those indicated by our forward-looking statements. Please read the safe harbor statement contained in our most recent SEC filings as well as the risk factors contained in Precigen’s filings.
With that, I would like to now turn the call over to Dr. Sabzevari. Helen?
Helen Sabzevari
Thank you, Steve, and thank you to all for taking the time to join us for our year end 2024 update. It is indeed a transformative time for at Precigen and as we are on the verge of commercializing our lead
Read the full article here